1 Min Read
Nov 20 (Reuters) - DBV TECHNOLOGIES
* SAYS ANNOUNCES POSITIVE RESULTS FOR PHASE III TRIAL REGARDING VIASKIN PEANUT ALLERGY TREATMENT See also:
Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.